Table Legend -
Table 1 – Control animals (aCSF) and treated with an NMDA
receptor antagonist (LY235959 - 1nmol/100nL) and a non-NMDA receptor
antagonist (NBQX - 1nmol/100nL). Result of the test of difference of
means (student t test) of baseline values of MAP, HR and TST, before and
after drug injection. Values expressed as mean ±SEM.
Footnotes – aCSF - artificial cerebrospinal fluid; NBQX -
2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide;
LY235959 -
[3S-(3α,4aα,6β,8aα)]-Decahydro-6-(phosphonomethyl)-3-isoquinolinecarboxylic
acid); MAP - mean blood pressure; HR - heart rate; TST – tail skin
temperature; bpm - beats per minute; mmHg - millimeters of mercury; ºC -
degree Celsius.
Table 2 – Control animals (aCSF) and treated with an NMDA
receptor antagonist (LY235959 - 1nmol/100nL) and a non-NMDA receptor
antagonist (NBQX - 1nmol/100nL). Result of the test of difference of
means (student t test) of baseline values in the sequences of BEI (Up),
BEI (Down) and BEI (All), before and after drug injection. Values
expressed as mean ±SEM.
Footnotes – aCSF - artificial cerebrospinal fluid; NBQX -
2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide;
LY235959 -
[3S-(3α,4aα,6β,8aα)]-Decahydro-6-(phosphonomethyl)-3-isoquinolinecarboxylic
acid); BEI - baroreflex effectiveness index
Table 3 - Control animals (aCSF) and treated with an NMDA
receptor antagonist (LY235959 - 1nmol/100nL) and a non-NMDA receptor
antagonist (NBQX - 1nmol/100nL). Result of the test of difference of
means (student t test) of baseline values in the sequences of Gain (Up),
Gain (Down) and Gain (All), before and after drug injection. Values
expressed as mean ± SEM
Footnotes – aCSF - artificial cerebrospinal fluid; NBQX -
2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide;
LY235959 -
[3S-(3α,4aα,6β,8aα)]-Decahydro-6-(phosphonomethyl)-3-isoquinolinecarboxylic
acid);